Related Experiment Video
Updated: Aug 24, 2026
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Expression of cytochrome P450 in lung tumor
Negar Gharavi1, Ayman O S El-Kadi
1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada T6G 2N8.
Abstract:
Cytochrome P450 (CYP450) enzymes have the capability of playing key metabolic roles in several aspects of cancer as a consequence of their unusually broad substrate specificities. CYP450 are also prominent players in the metabolism of anticancer therapeutic drugs, enhancing or diminishing the efficacy of the drugs depending on whether the drug or its metabolites are efficacious. As CYP450 enzymes are also found in lung tissue, lung metabolism can be of importance to the bioactivation of some anticancer agents. The presence of individual forms of CYP450 has been investigated in lung tumor to determine whether intra-tumor metabolism of anticancer agents by CYP450 could occur and thus influence the response of tumor to these agents. Differences in drug metabolism between normal and cancerous lung tissue have been shown to exist, therefore; the variable expression of CYP450 between tumor and normal tissue can provide a basis for selective sensitivity of tissue to anticancer drugs, thereby localizing drug actions to tumor. This review gives a detailed picture of the expression of CYP450 in lung tumor and the role of this enzyme in lung tumor in the fate of anticancer drugs.
Insights
Cytochrome P450 (CYP450) enzymes in lung tumors metabolize anticancer drugs, affecting treatment efficacy. Understanding CYP450 expression in lung tumors is crucial for targeted cancer therapy.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Cytochrome P450 (CYP450) enzymes are crucial for drug metabolism due to their broad substrate specificities.
- These enzymes significantly influence the efficacy of anticancer therapeutics by activating or deactivating drugs.
- CYP450s are present in lung tissue, impacting the metabolism and bioactivation of anticancer agents.
Purpose of the Study:
- To investigate the expression of individual CYP450 forms within lung tumors.
- To determine if intra-tumor metabolism of anticancer agents by CYP450 occurs.
- To assess the influence of CYP450-mediated metabolism on tumor response to anticancer drugs.
Main Methods:
- Review of existing literature on CYP450 expression in lung tumors.
- Analysis of studies investigating CYP450 activity in lung cancer tissue.
- Comparison of CYP450 expression profiles between normal and cancerous lung tissue.
Main Results:
- Variable expression of CYP450 enzymes has been observed in lung tumors.
- Differences in drug metabolism exist between normal and cancerous lung tissues.
- Intra-tumor metabolism by CYP450 can influence the fate and efficacy of anticancer drugs.
Conclusions:
- Variable CYP450 expression between tumor and normal tissue offers a basis for selective drug targeting.
- Understanding lung tumor CYP450 profiles can lead to localized drug actions and improved therapeutic outcomes.
- CYP450 enzymes play a significant role in the bioactivation and deactivation of anticancer drugs within the lung tumor microenvironment.